Publication:
Lipid-laden macrophages in atherosclerosis and cancer.

dc.contributor.authorMartinez-Campanario, M C
dc.contributor.authorCortés, Marlies
dc.contributor.authorHan, Lu
dc.contributor.authorBrischetto, Agnese
dc.contributor.authorRivero-Soriano, Paloma
dc.contributor.authorFont-Díaz, Joan
dc.contributor.authorMaurel, Joan
dc.contributor.authorAndrés, Vicente
dc.contributor.authorPostigo, Antonio
dc.date.accessioned2026-10-14T13:54:53Z
dc.date.available2026-10-14T13:54:53Z
dc.date.issued2025-12
dc.description.abstractThis review explores the dual roles of lipid-laden macrophages (LL-Macs) in inflammation, atherosclerosis and cancer, emphasizing both their shared and divergent functions across physiological and pathological conditions. Lipid metabolism regulates the polarization of macrophages in homeostasis and inflammation. In atherosclerosis, LL-Macs contribute to plaque formation and inflammation, while in cancer, LL-Macs play crucial roles in immune suppression and tumor progression. The article outlines the molecular mechanisms driving macrophage lipid accumulation in each of these scenarios and how the process is influenced by the distinct local microenvironments in inflammation, atherosclerosis and cancer. Single-cell RNA sequencing (scRNA-seq) studies have identified both common and unique gene signatures between LL-Macs in atherosclerosis and cancer, reflecting the varying microenvironmental cues that shape macrophage function and disease outcomes. Finally, we examine lipid-modulating strategies in atherosclerosis, assess their potential in cancer treatment, and highlight research gaps for developing new LL-Macs targeted therapies in cancer.
dc.description.peerreviewedSí
dc.description.tableofcontentsWork in the group related to this review is funded by grants to AP from the Spanish National Research Agency/Ministry of Science, Innovation, and Universities (MICIU/AEI) (reference PID2023–146522OBI00 funded by MICIU/AEI/10.13039/501100011033 and the European Union Regional Development Fund, EU-FEDER), Catalan Agency for Management of University and Research Grants (AGAUR) (2021-SGR01328), Olga Torres Foundation (Biannual Grant 19/20), and Avon SAU Foundation. LH is supported by a PhD scholarship from the China Scholarship Council (reference 202208110041). PRS’s salary is funded by a PhD scholarship from MICIU/AEI (reference PRE2021–100032). JFD’s salary is funded by a Juan de la Cierva postdoctoral scholarship from MICIU/AEI (reference JDC2023–051880-I). CNIC is supported by Carlos III Health Institute, MICIU, and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020–001041-S funded by MICIU/AEI/10.13039/501100011033).
dc.format.page38
dc.format.volume117
dc.identifier.citationSemin Cancer Biol. 2025 Dec:117:38-56.
dc.identifier.doi10.1016/j.semcancer.2025.09.007
dc.identifier.e-issn1096-3650
dc.identifier.journalSeminars in cancer biology
dc.identifier.pubmedID41005549
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27759
dc.language.isoeng
dc.relation.isreferencedbyPubMed
dc.relation.publisherversion10.1016/j.semcancer.2025.09.007
dc.repisalud.institucionCNIC
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAtherosclerosis
dc.subjectCancer
dc.subjectImmunosuppression
dc.subjectLipid metabolism
dc.subjectLipid-laden macrophages
dc.subjectTumor-associated macrophages
dc.subject.meshHumans
dc.subject.meshAnimals
dc.subject.meshInflammation
dc.subject.meshTumor Microenvironment
dc.titleLipid-laden macrophages in atherosclerosis and cancer.
dc.typereview article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Lipid_laden macrophages in atherosclerosis and cancer_Semin Cancer Biol_2025.pdf
Size:
5.62 MB
Format:
Adobe Portable Document Format